Evidence for Epigenetic Alterations in Turner Syndrome Opens up Feasibility of New Pharmaceutical Interventions

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|11|1778-1785

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1778-1785

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Feasibility of fertility preservation in young females with Turner syndrome

By Lau Nga Man   Huang Jack Yu Jen   MacDonald Suzanne   Elizur Shai   Gidoni Yariv   Holzer Hananel   Chian Ri-Cheng   Tulandi Togas   Tan Seang Lin  

Reproductive BioMedicine Online, Vol. 18, Iss. 2, 2009-02 ,pp. : 290-295

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Pharmaceutical Interventions to Influence Arteriogenesis: New Concepts to Treat Ischemic Heart Disease

By  

Current Medicinal Chemistry, Vol. 13, Iss. 9, 2006-04 ,pp. : 979-987

Bentham Science Publishers

Access to resources Recommend Favorite

Aspects of the treatment of Turner syndrome

By Gravholt Claus Højbjerg  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1633-1647

Informa Healthcare

Access to resources Recommend Favorite

Pharmaceutical Interventions for Frailty and Sarcopenia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 18, 2014-06 ,pp. : 3068-3082

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1857-1865

Bentham Science Publishers

Access to resources Recommend Favorite